Adverse Event Management

Precision Dosing in Chronic Myeloid Leukemia: Navigating the Intersection of TKI Efficacy and Long-term Tolerability

This clinical review examines the management of treatment-emergent adverse events (TEAEs) in patients with chronic myeloid leukemia. It highlights strategies for dose optimization and proactive toxicity management to balance molecular respo